Literature DB >> 11598073

Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

M Watanabe1, M Nagai.   

Abstract

The protective immunity induced by infection with Bordetella pertussis and with Bordetella parapertussis was examined in a murine model of respiratory infection. Convalescent mice that had been infected by aerosol with B. pertussis or with B. parapertussis exhibited a protective immune response against B. pertussis and also against B. parapertussis. Anti-filamentous hemagglutinin (anti-FHA) serum immunoglobulin G (IgG) and anti-FHA lung IgA antibodies were detected in both mice infected with B. pertussis and those infected with B. parapertussis. Antibodies against pertussis toxin (anti-PT) and against killed B. pertussis cells were detected in mice infected with B. pertussis. Pertactin-specific antibodies and antibodies against killed B. parapertussis cells were detected in mice infected with B. parapertussis. Spleen cells from mice infected with B. pertussis secreted interferon-gamma (IFN-gamma) in response to stimulation by FHA or PT. Spleen cells from mice infected with B. parapertussis also secreted IFN-gamma in response to FHA. Interleukin-4 was not produced in response to any of the antigens tested. The profiles of cytokine secretion in vitro revealed induction of a Th1-biased immune response during convalescence from infection by B. pertussis and by B. parapertussis. It is possible that Th1 and Th2 responses against FHA might be related to the reciprocal protection achieved in our murine model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598073      PMCID: PMC100078          DOI: 10.1128/IAI.69.11.6981-6986.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Antibody response to pertussis toxin and filamentous haemagglutinin in NIH mice immunized with the International Standard for Pertussis Vaccine.

Authors:  M A Manghi; N I Dellepiane; P V Eriksson; G Di Paola; F H De Dios
Journal:  Biologicals       Date:  1990-07       Impact factor: 1.856

2.  Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.

Authors:  F D Menozzi; C Gantiez; C Locht
Journal:  FEMS Microbiol Lett       Date:  1991-02       Impact factor: 2.742

3.  Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis.

Authors:  J L Gould-Kostka; D L Burns; M J Brennan; C R Manclark
Journal:  FEMS Microbiol Lett       Date:  1990-02       Impact factor: 2.742

4.  Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-sepharose affinity chromatography.

Authors:  P Chong; M Klein
Journal:  Biochem Cell Biol       Date:  1989-07       Impact factor: 3.626

5.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

Authors:  B Aricò; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

6.  Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.

Authors:  R D Sekura; F Fish; C R Manclark; B Meade; Y L Zhang
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

7.  Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.

Authors:  M Oda; J L Cowell; D G Burstyn; C R Manclark
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

9.  Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house.

Authors:  S Iwata; T Aoyama; A Goto; H Iwai; Y Sato; H Akita; Y Murase; T Oikawa; T Iwata; S Kusano
Journal:  Dev Biol Stand       Date:  1991

10.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more
  10 in total

1.  Imperfect vaccine-induced immunity and whooping cough transmission to infants.

Authors:  Jennie Lavine; Hélène Broutin; Eric T Harvill; Ottar N Bjørnstad
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

2.  Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Eric T Harvill
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates.

Authors:  Paola Stefanelli; Maurizio Sanguinetti; Cecilia Fazio; Brunella Posteraro; Giovanni Fadda; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

5.  Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

Authors:  Mineo Watanabe; Masaaki Nagai
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

6.  The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.

Authors:  Daniel N Wolfe; Elizabeth M Goebel; Ottar N Bjornstad; Olivier Restif; Eric T Harvill
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

7.  Role of antibodies in immunity to Bordetella infections.

Authors:  Girish S Kirimanjeswara; Paul B Mann; Eric T Harvill
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

8.  Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.

Authors:  Nathalie Mielcarek; Anne-Sophie Debrie; Dominique Raze; Julie Bertout; Carine Rouanet; Amena Ben Younes; Colette Creusy; Jacquelyn Engle; William E Goldman; Camille Locht
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

9.  The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.

Authors:  Sander Banus; Rachel M Stenger; Eric R Gremmer; Jan A M A Dormans; Frits R Mooi; Tjeerd G Kimman; Rob J Vandebriel
Journal:  BMC Immunol       Date:  2008-05-22       Impact factor: 3.615

10.  Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.

Authors:  Chukiat Sirivichayakul; Pornthep Chanthavanich; Kriengsak Limkittikul; Claire-Anne Siegrist; Wassana Wijagkanalan; Pailinrut Chinwangso; Jean Petre; Pham Hong Thai; Mukesh Chauhan; Simonetta Viviani
Journal:  Hum Vaccin Immunother       Date:  2016-09-29       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.